MedTrace Logo

The Efficacy of Implementing a Treatment Algorithm in Managing Patent Ductus Arteriosus (PDA) in the Extremely Low Birth Weight Neonatal Population.

NCT04379843 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 208

Last updated 2021-09-01

No results posted yet for this study

Summary

To evaluate whether utilizing a standardized patent ductus arteriosus (PDA) treatment algorithm in managing ELBW (extremely low birth weight) neonates ≤1000 grams (g) improves clinical outcomes and helps prevent undesirable side effects from PDAs.

Conditions

  • PDA
  • Low; Birthweight, Extremely (999 Grams or Less)

Sponsors & Collaborators

  • Banner University Medical Center

    collaborator OTHER

  • Pediatrix

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-27
Primary Completion
2020-07-17
Completion
2021-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04379843 on ClinicalTrials.gov